With the July 8, 2026, compliance deadline in effect, covered providers should ensure they have the required accessible equipment, train staff, and review operational practices to reduce compliance risk and provide accessible care for patients with disabilities
Common Tirzepatide Side Effects and How to Handle Them If you are thinking about using Mounjaro for diabetes or weight management support, you probably want to know what side effects to expect
It is generally not recommended to stop GLP-1 therapy abruptly unless under strict medical supervision
PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and 150+ genetic insights, including variants affecting lipid regulation and GLP-1/GIP receptor function
Unlike low-fat or low-carb cycles, GLP-1-driven behavior change does not require willpower it is physiological, and it compounds as adoption grows
Update: Plaintiffs Request that Ozempic-Related Vision Loss Cases Be Consolidated in New Jersey On June 12, 2025, five law firms representing 21 plaintiffs alleging GLP-1-related injuries submitted a letter to the Administrative Office of the Courts requesting that their lawsuits be designated as a Multicounty Litigation (MCL) in New Jersey State Court